Clinical Trials for Children With Cancer

Most children with cancer in the United States are treated as part of a clinical trial. This surprises a lot of parents. It does not mean your child is a guinea pig. It usually means your child gets the current best standard treatment, tracked closely, sometimes alongside a promising new option.

Childhood cancer is rare, and each type is even rarer. No single hospital sees enough cases alone to learn quickly. The Children's Oncology Group, or COG, links hospitals across the country and beyond. Together, they enroll children in shared trials. This is a big reason survival for childhood cancer has improved so much over the past 50 years. Progress came largely through steady, careful trial results, not one breakthrough at a time.

Many pediatric trials are not testing an experimental drug against nothing. Often, every child on the trial gets the accepted standard treatment. The trial's real purpose is to answer a specific question: does adding a new drug help? Does a lower dose work just as well with fewer side effects? Being in a trial usually means more monitoring, not less care.

Before your child joins a trial, the team walks you through informed consent. This means explaining the trial's purpose, the treatment plan, the known risks and possible benefits, and what alternatives exist outside the trial. You can ask questions and take time to decide. For children old enough to understand, doctors also seek their assent — an age-appropriate yes, on top of your consent — because respecting a child's voice matters, even when the final decision is yours.

Joining a trial is always voluntary. Declining does not mean your child gets worse care; it means your team builds a treatment plan outside the trial structure instead. Some families want every possible option explored. Others prefer the most established path. Both are reasonable. Ask your team to explain, in plain language, exactly what changes for your child if you say yes, and what stays the same if you say no.

Being in a trial usually means a more detailed schedule of tests, scans, and blood work than standard care alone. This is by design: it protects your child and produces reliable results for future patients. You can typically leave a trial at any time, for any reason, without it affecting your child's regular care.

Ask what question this specific trial is trying to answer. Ask what the treatment plan looks like on the trial, compared with the standard approach off the trial. Ask what extra tests or visits the trial requires. Ask about known side effects, and how the team will manage them. Ask whether you can change your mind later, and what that would involve.

Pediatric trials go through extra layers of review before children can join. An institutional review board checks the trial plan for safety and fairness before it opens. A data and safety monitoring board watches results as the trial runs, and can stop a trial early if a problem shows up or if one treatment is clearly working better. This oversight exists specifically because children cannot fully weigh risks and benefits the way adults can, so extra outside checking fills that gap.

Ask your team, in writing if possible, what costs the trial covers and what your insurance covers. Standard-of-care parts of treatment are usually billed the normal way. Trial-specific tests are sometimes covered by the study itself. Some trials also help with travel costs, since not every hospital runs every trial. A social worker or research coordinator can walk you through exactly what to expect financially before you decide.

Your child's oncologist is the first and best source for trials your child may qualify for. NCI's clinical trial search tool, at cancer.gov, lists federally supported trials by cancer type and location. The Children's Oncology Group's website also lists member institutions running COG trials.

• National Cancer Institute — Children with Cancer: A Guide for Parents.
• National Cancer Institute — Find a Clinical Trial.